Related Experiment Video
Updated: Apr 14, 2026
Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells
Published on: December 11, 2020
Gamma-tocotrienol treatment increased peroxiredoxin-4 expression in HepG2 liver cancer cell line
Farahani Abdul Rahman Sazli1, Zakiah Jubri2, Mariati Abdul Rahman3
1Department of Biochemistry, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia. farahsazli@gmail.com.
Background:
To determine the antiproliferative effect of gamma-tocotrienol (GTT) treatment on differential protein expression in HepG2 cells.
Methods:
HepG2 cells were treated with 70 μM GTT for 48 hours and differentially expressed protein spots were determined by two-dimensional electrophoresis (2DE), identified by MALDI-TOF mass spectrometer (MS) and validated by quantitative real-time polymerase chain reaction (qRT-PCR).
Results:
GTT treatment on HepG2 cells showed a total of five differentially expressed proteins when compared to their respective untreated cells where three proteins were down-regulated and two proteins were up-regulated. One of these upregulated proteins was identified as peroxiredoxin-4 (Prx4). Validation by qRT-PCR however showed decreased expression of Prx4 mRNA in HepG2 cells following GTT treatment.
Conclusions:
GTT might directly influence the expression dynamics of peroxiredoxin-4 to control proliferation in liver cancer.
Insights
Gamma-tocotrienol (GTT) affects liver cancer cell protein expression, down-regulating some proteins and up-regulating others, including peroxiredoxin-4 (Prx4). This suggests GTT may control liver cancer proliferation by influencing Prx4 dynamics.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Hepatocellular carcinoma (HCC) remains a significant global health challenge.
- Understanding the molecular mechanisms underlying HCC proliferation is crucial for developing targeted therapies.
- Gamma-tocotrienol (GTT), a vitamin E derivative, has shown potential anticancer properties.
Purpose of the Study:
- To investigate the antiproliferative effects of gamma-tocotrienol (GTT) on HepG2 liver cancer cells.
- To identify differentially expressed proteins in HepG2 cells following GTT treatment.
- To elucidate the role of specific proteins, such as peroxiredoxin-4 (Prx4), in GTT-mediated effects.
Main Methods:
- HepG2 cells were treated with 70 μM GTT for 48 hours.
- Differential protein expression was analyzed using two-dimensional electrophoresis (2DE).
- Protein identification was performed using MALDI-TOF mass spectrometry (MS), and mRNA expression was validated by quantitative real-time polymerase chain reaction (qRT-PCR).
Main Results:
- GTT treatment resulted in five differentially expressed proteins in HepG2 cells: three down-regulated and two up-regulated.
- Peroxiredoxin-4 (Prx4) was identified as one of the up-regulated proteins at the proteomic level.
- Quantitative real-time polymerase chain reaction (qRT-PCR) validation revealed decreased Prx4 mRNA expression post-GTT treatment, indicating post-transcriptional regulation.
Conclusions:
- Gamma-tocotrienol (GTT) exhibits antiproliferative effects on HepG2 liver cancer cells.
- GTT influences the expression of specific proteins, including peroxiredoxin-4 (Prx4).
- GTT may modulate liver cancer proliferation through direct influence on Prx4 expression dynamics, potentially at a post-transcriptional level.
